Jungersted JM et al. |
Effects of topical corticosteroid and tacrolimus on ceramides and irritancy to sodium lauryl sulphate in healthy skin. |
2011 |
Acta Derm. Venereol. |
pmid:21365172
|
Campione E et al. |
Combination of low-dosage cyclosporine and topical pimecrolimus in severe atopic dermatitis with chronic hepatitis B. |
2008 |
Acta Derm. Venereol. |
pmid:18176762
|
Laeijendecker R et al. |
A comparison of treatment of oral lichen planus with topical tacrolimus and triamcinolone acetonide ointment. |
2006 |
Acta Derm. Venereol. |
pmid:16710580
|
Hao D et al. |
Lymphocytic infiltration of the eyelid: two cases responding to tacrolimus and topical glucocorticoid. |
2013 |
Acta Derm. Venereol. |
pmid:23423497
|
Seo SR et al. |
Disrupted Skin Barrier is Associated with Burning Sensation after Topical Tacrolimus Application in Atopic Dermatitis. |
2017 |
Acta Derm. Venereol. |
pmid:28512670
|
Mandelin J et al. |
One-year treatment with 0.1% tacrolimus ointment versus a corticosteroid regimen in adults with moderate to severe atopic dermatitis: A randomized, double-blind, comparative trial. |
2010 |
Acta Derm. Venereol. |
pmid:20169301
|
Ujiie H et al. |
Successful treatment of nail lichen planus with topical tacrolimus. |
2010 |
Acta Derm. Venereol. |
pmid:20169322
|
Weisshaar E |
Successful treatment of genital pruritus using topical immunomodulators as a single therapy in multi-morbid patients. |
2008 |
Acta Derm. Venereol. |
pmid:18311464
|
Inoue T et al. |
Prolonged topical application of tacrolimus inhibits immediate hypersensitivity reactions by reducing degranulation of mast cells. |
2006 |
Acta Derm. Venereol. |
pmid:16585982
|
Ortonne JP et al. |
0.3% Tacrolimus gel and 0.5% Tacrolimus cream show efficacy in mild to moderate plaque psoriasis: Results of a randomized, open-label, observer-blinded study. |
2006 |
Acta Derm. Venereol. |
pmid:16585986
|
Tzung TY et al. |
Pimecrolimus and narrowband UVB as monotherapy or combination therapy in children and adolescents with atopic dermatitis. |
2006 |
Acta Derm. Venereol. |
pmid:16585987
|
Pitarch G et al. |
Systemic absorption of topical tacrolimus in Pyoderma gangrenosum. |
2006 |
Acta Derm. Venereol. |
pmid:16585995
|
Cunha PR |
Pimecrolimus cream 1% is effective in seborrhoeic dermatitis refractory to treatment with topical corticosteroids. |
2006 |
Acta Derm. Venereol. |
pmid:16585998
|
Kirsner RS et al. |
Safety and efficacy of tacrolimus ointment versus pimecrolimus cream in the treatment of patients with atopic dermatitis previously treated with corticosteroids. |
2010 |
Acta Derm. Venereol. |
pmid:20107727
|
Fukamachi S et al. |
Therapeutic effectiveness of various treatments for eosinophilic pustular folliculitis. |
2009 |
Acta Derm. Venereol. |
pmid:19326000
|
Jacobs F et al. |
New approach in combined therapy of perifolliculitis capitis abscedens et suffodiens. |
2011 |
Acta Derm. Venereol. |
pmid:21681358
|
Hartmann A et al. |
Occlusive treatment enhances efficacy of tacrolimus 0.1% ointment in adult patients with vitiligo: results of a placebo-controlled 12-month prospective study. |
2008 |
Acta Derm. Venereol. |
pmid:18779885
|
Ambo M |
Relapsing Kaposi's varicelliform eruption and herpes simplex following facial tacrolimus treatment for atopic dermatitis. |
2002 |
Acta Derm. Venereol. |
pmid:12353724
|
De Rie MA et al. |
Soluble interleukin-2 receptor (sIL-2R) is a marker of disease activity in psoriasis: a comparison of sIL-2R, sCD27, sCD4, sCD8 and sICAM-1. |
1996 |
Acta Derm. Venereol. |
pmid:8891007
|
Yamamoto T and Nishioka K |
Topical tacrolimus is effective for facial lesions of psoriasis. |
2000 Nov-Dec |
Acta Derm. Venereol. |
pmid:11243645
|